ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Mikaela Naylon Give Kids A Chance Act (HR 1262), Give Kids A Chance Act (S 932), Cameron's Law (HR 1414), Kids Access to Care Act (Accelerating HR 1509, S 752), Small Biotech Innovations Act (HR 3731, S 1930), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL MATTOON | — |
| SARAH TODD TELLOCK | — |
Medicare/Medicaid MMM
Alzheimers Screening and Prevention (ASAP) Act (H.R. 6130 / S. 3267) Implementation of the Inflation Reduction Act of 2022, ORPHAN Cures Act (HR 946, S 1862), Accelerating Kids Access to Care Act (HR 1509, S 752), EPIC Act (HR 1492, S 832), One Big Beautiful Bill Act (HR 1), Issues related to protecting patient access to medicines in Medicare and Medicaid, Issues related to access to medicines for Parkinson's disease patients, Issues related to Antipsychotic use in Medicare, Issues related to most-favored-nation policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL MATTOON | — |
| SARAH TODD TELLOCK | — |
Taxation/Internal Revenue Code TAX
Cameron's Law (HR 1414), One Big Beautiful Bill Act (HR 1).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL MATTOON | — |
| SARAH TODD TELLOCK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.